In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin.
Where this comes from
- Record sourced from PubMed, PMID 38560907.
- Also identified by DOI 10.7326/J24-0015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cesta CE, Rotem R, Bateman BT, et al. <b>Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy.</b> JAMA Intern Med. 2024;184:144-152. 38079178.
Medical subject headings
- Insulin
- Diabetes Mellitus, Type 2